US EditionPublished • loading... • Updated
Northwest Biotherapeutics: Q3 Earnings Snapshot - The Morning Sun
Summary by Morning Sun
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Northwest Biotherapeutics: Q3 Earnings Snapshot - The Morning Sun
BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $26.8 million in its third quarter. On a per-share basis, the Bethesda, Maryland-based company said it had a loss of $18.22. The cancer drug developer posted revenue of $200,000 in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks st…
·Pittsburg, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
